Clinical Trials
13
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Fertility in Healthy Premenopausal Women
- Conditions
- Fertility
- First Posted Date
- 2016-05-16
- Last Posted Date
- 2016-08-10
- Lead Sponsor
- Fujirebio Diagnostics, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT02772848
- Locations
- 🇺🇸
Vita Pharma, Hialeah, Florida, United States
🇺🇸American Blood Bank, Inc., Miami, Florida, United States
A Prospective Collection of Peripheral Blood and Urine Specimens to Study C-peptide and Insulin in Healthy Individuals
- Conditions
- Diabetes
- First Posted Date
- 2015-11-25
- Last Posted Date
- 2016-08-10
- Lead Sponsor
- Fujirebio Diagnostics, Inc.
- Target Recruit Count
- 328
- Registration Number
- NCT02614170
- Locations
- 🇺🇸
Fundamental Research LLC, Gulf Shores, Alabama, United States
Blood Collection of Patient Presenting in the ED and Prescribed a BNP
- Conditions
- Heart Failure
- First Posted Date
- 2015-11-25
- Last Posted Date
- 2016-08-10
- Lead Sponsor
- Fujirebio Diagnostics, Inc.
- Target Recruit Count
- 400
- Registration Number
- NCT02614209
- Locations
- 🇺🇸
University of Maryland, Baltimore, Maryland, United States
🇺🇸Henry Ford Health System, Detroit, Michigan, United States
A Prospective Longitudinal Breast Cancer Study
- Conditions
- Breast Cancer
- First Posted Date
- 2014-10-22
- Last Posted Date
- 2021-08-17
- Lead Sponsor
- Fujirebio Diagnostics, Inc.
- Target Recruit Count
- 130
- Registration Number
- NCT02270931
- Locations
- 🇺🇸
Jane Skelton, MD, Boca Raton, Florida, United States
🇺🇸Broward Health Medical Center, Fort Lauderdale, Florida, United States
🇺🇸New Hanover Regional Medical Center, Wilmington, North Carolina, United States
Study Vitamin D in Healthy Individuals
- Conditions
- Vitamin D Deficiency
- First Posted Date
- 2014-09-26
- Last Posted Date
- 2015-05-22
- Lead Sponsor
- Fujirebio Diagnostics, Inc.
- Target Recruit Count
- 482
- Registration Number
- NCT02250625
- Locations
- 🇺🇸
Open Medicine Institute, Mountain View, California, United States
- Prev
- 1
- 2
- 3
- Next
News
Fujirebio Acquires Plasma Services Group to Strengthen Rare Disease Biomarker Supply Chain
Fujirebio Diagnostics has acquired all shares of Plasma Services Group, a specialized supplier of rare biological materials for in vitro diagnostics and life science research since 2004.
AriBio and Fujirebio Complete Major Biomarker Sample Collection for Alzheimer's Research in Phase 3 POLARIS-AD Trial
AriBio and Fujirebio Diagnostics have completed a significant biomarker sample collection from over 1,150 participants in the Phase 3 POLARIS-AD trial for early Alzheimer's disease.